AAAAAA

   
Results: 1-14 |
Results: 14
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer
Authors: Nijman, HW van Diest, PJ Poort-Keesom, RJJ von Mensdorff-Pouilly, S Verstraeten, RA Kummer, A Meijer, CJLM Melief, CJM Hilgers, J Kenemans, P
Citation: Hw. Nijman et al., T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer, EUR J OB GY, 94(1), 2001, pp. 114-120
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients
Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA Livingston, PO Hilgers, J Kenemans, P
Citation: Fgm. Snijdewint et al., Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients, INT J CANC, 93(1), 2001, pp. 97-106
Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy inpatients with breast cancer
Authors: Scholl, SM Balloul, JM Le Goc, G Bizouarne, N Schatz, C Kieny, MP von Mensdorff-Pouilly, S Vincent-Salomon, A Deneux, L Tartour, E Fridman, W Pouillart, P Acres, B
Citation: Sm. Scholl et al., Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy inpatients with breast cancer, J IMMUNOTH, 23(5), 2000, pp. 570-580
Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1
Authors: Ryuko, K Schol, DJ Snijdewint, FGM von Mensdorff-Pouilly, S Poort-Keesom, RJJ Karuntu-Wanamarta, YA Verstraeten, RA Miyazaki, K Kenemans, P Hilgers, J
Citation: K. Ryuko et al., Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1, TUMOR BIOL, 21(4), 2000, pp. 197-210
Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
Authors: von Mensdorff-Pouilly, S Verstraeten, AA Kenemans, P Snijdewint, FGM Kok, A Van Kamp, GJ Paul, MA Van Diest, PJ Meijer, S Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin, J CL ONCOL, 18(3), 2000, pp. 574-583
Human MUC1 mucin: a multifaceted glycoprotein
Authors: von Mensdorff-Pouilly, S Snijdewint, FGM Verstraeten, AA Verheijen, RHM Kenemans, P
Citation: S. Von Mensdorff-pouilly et al., Human MUC1 mucin: a multifaceted glycoprotein, INT J B MAR, 15(4), 2000, pp. 343-356
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides
Authors: von Mensdorff-Pouilly, S Petrakou, E Kenemans, P van Uffelen, K Verstraeten, AA Snijdewint, FGM van Kamp, GJ Schol, DJ Reis, CA Price, MR Livingston, PO Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1peptides and N-acetylgalactosamine (GalNAc) peptides, INT J CANC, 86(5), 2000, pp. 702-712
Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma
Authors: Treon, SP Maimonis, P Bua, D Young, G Raje, N Mollick, J Chauhan, D Tai, YT Hideshima, T Shima, Y Hilgers, J von Mensdorff-Pouilly, S Belch, AR Pilarski, LM Anderson, KC
Citation: Sp. Treon et al., Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma, BLOOD, 96(9), 2000, pp. 3147-3153
Detection of humoral immune responses to mucins
Authors: von Mensdorff-Pouilly, S Vennegoor, C Hilgers, J
Citation: S. Von Mensdorff-pouilly et al., Detection of humoral immune responses to mucins, METH MOL B, 125, 2000, pp. 495-500
CA 125: fundamental and clinical aspects
Authors: Verheijen, RHM von Mensdorff-Pouilly, S van Kamp, GJ Kenemans, P
Citation: Rhm. Verheijen et al., CA 125: fundamental and clinical aspects, SEM CANC B, 9(2), 1999, pp. 117-124
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls
Authors: Snijdewint, FGM von Mensdorff-Pouilly, S Karuntu-Wanamarta, AH Verstraeten, AA van Zanten-Przybysz, I Hummel, P Nijman, HW Kenemans, P Hilgers, J
Citation: Fgm. Snijdewint et al., Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls, CANCER IMMU, 48(1), 1999, pp. 47-55
Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes byimmunomagnetic beads
Authors: Petrarca, C Casalino, B von Mensdorff-Pouilly, S Rughetti, A Rahimi, H Scambia, G Hilgers, J Frati, L Nuti, M
Citation: C. Petrarca et al., Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes byimmunomagnetic beads, CANCER IMMU, 47(5), 1999, pp. 272-277
Quantification of MUC1 in breast cancer patients - A method comparison study
Authors: Bon, GG van Kamp, GJ Verstraeten, RA von Mensdorff-Pouilly, S Hilgers, J Kenemans, P
Citation: Gg. Bon et al., Quantification of MUC1 in breast cancer patients - A method comparison study, EUR J OB GY, 83(1), 1999, pp. 67-75
Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast
Authors: Mommers, ECM Leonhart, AM von Mensdorff-Pouilly, S Schol, DJ Hilgers, J Meijer, CJLM Baak, JPA van Diest, PJ
Citation: Ecm. Mommers et al., Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma in situ of the breast, INT J CANC, 84(5), 1999, pp. 466-469
Risultati: 1-14 |